Aspire Biopharma unit hires John Choe as western sales director

Published 03/17/2026, 08:33 AM

Aspire Biopharma Holdings Inc. (ASBP) announced that its subsidiary Buzz Bomb Caffeine Company has appointed John Choe as Western Sales Director.

Choe brings 25 years of industry experience to the role. He previously served as District Manager at Yerbaé from 2016 to 2025, where the company reported he achieved a 70% increase in overall sales in the natural energy drink category.

His career includes positions at Nike (1999-2005), where he managed accounts including Nordstrom in California; Mars Candy (2005-2009), leading sales efforts for retailers including Walmart, Target, and Safeway; and Bosch (2009-2012), handling training for Home Depot, Lowe’s, and Ace Hardware.

"John’s deep expertise in the beverage and retail sectors, combined with a visionary approach to market analysis and consumer engagement, makes him an ideal leader to spearhead our sales strategy in the western United States," stated Kraig Higginson, Interim CEO of Aspire Biopharma.

Choe holds a Master of Business Administration from the University of Phoenix and a Bachelor of Science in Business Management from the University of Utah. He speaks Korean, Chinese, and Japanese.

"I am thrilled to join BUZZ BOMB at such a pivotal moment in its growth trajectory," Choe said. "The energy category is evolving quickly, and I look forward to leveraging my experience in retail partnerships to expand our footprint and bring Buzz Bomb’s innovative products to a wider audience."

The appointment was announced in a company press release.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.